Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan

BACKGROUND: Understanding the neutralizing antibody (NAb) titer against COVID-19 over time is important to provide information for vaccine implementation. The longitudinal NAb titer over one year after SARS-CoV-2 infection is still unclear. The purposes of this study are to evaluate the duration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yen-Fang, Hsu, Fang-Chi, Wu, Jiunn-Jong, Lin, Yi-Ling, Liu, Ming-Tsan, Yang, Chin-Hui, Kuo, Hsu-Sung, Chen, Yen-Ju, Cheng, Chien-Yu, Lin, His-Hsun, Liao, Chun-Che, Chang, Chih-Shin, Liang, Jian-Jong, Cheng, Wen-Yueh, Huang, Jason C., Chen, Cheng-Pin, Cheng, Shu-Hsing, Lin, Yi-Chun, Yang, Shung-Haur, Chou, Yiing-Jenq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019033/
https://www.ncbi.nlm.nih.gov/pubmed/36967265
http://dx.doi.org/10.1016/j.jmii.2023.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019033/
https://www.ncbi.nlm.nih.gov/pubmed/36967265
http://dx.doi.org/10.1016/j.jmii.2023.03.004

Ejemplares similares